IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by John, M.
Right arrow Articles by Calderwood, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by John, M.
Right arrow Articles by Calderwood, S. B.

 Previous Article  |  Next Article 

Infection and Immunity, May 2005, p. 2665-2679, Vol. 73, No. 5
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.5.2665-2679.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Use of In Vivo-Induced Antigen Technology for Identification of Escherichia coli O157:H7 Proteins Expressed during Human Infection

Manohar John,1,2,{dagger} Indira T. Kudva,1,2,{dagger}* Robert W. Griffin,1 Allen W. Dodson,1 Bethany McManus,1 Bryan Krastins,3 David Sarracino,3 Ann Progulske-Fox,4 Jeffrey D. Hillman,4 Martin Handfield,4 Phillip I. Tarr,5 and Stephen B. Calderwood1,2,6

Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts 02114,1 Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115,2 Harvard Partners Center For Genetics and Genomics, 65 Landsdowne Street, Cambridge, Massachusetts 02139,3 College of Dentistry, Department of Oral Biology, University of Florida, Gainesville, Florida 32610,4 Departments of Pediatrics and Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110,5 Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 021156

Received 4 November 2004/ Returned for modification 14 December 2004/ Accepted 12 January 2005

Using in vivo-induced antigen technology (IVIAT), a modified immunoscreening technique that circumvents the need for animal models, we directly identified immunogenic Escherichia coli O157:H7 (O157) proteins expressed either specifically during human infection but not during growth under standard laboratory conditions or at significantly higher levels in vivo than in vitro. IVIAT identified 223 O157 proteins expressed during human infection, several of which were unique to this study. These in vivo-induced (ivi) proteins, encoded by ivi genes, mapped to the backbone, O islands (OIs), and pO157. Lack of in vitro expression of O157-specific ivi proteins was confirmed by proteomic analysis of a mid-exponential-phase culture of E. coli O157 grown in LB broth. Because ivi proteins are expressed in response to specific cues during infection and might help pathogens adapt to and counter hostile in vivo environments, those identified in this study are potential targets for drug and vaccine development. Also, such proteins may be exploited as markers of O157 infection in stool specimens.


* Corresponding author. Mailing address: Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114. Phone: (617) 726-5694. Fax: (617) 726-7416. E-mail: ikudva{at}partners.org.

Editor: A. D. O'Brien

{dagger} Equal contribution.


Infection and Immunity, May 2005, p. 2665-2679, Vol. 73, No. 5
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.5.2665-2679.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2005 by the American Society for Microbiology. All rights reserved.